Ontogo Vascular Names Scott Rush as CEO

August 24, 2026—Ontogo Vascular Inc. announced the appointment of Scott Rush as Chief Executive Officer.

Radiation Detection Company’s Radiant Real-Time Dosimetry Launched for High-Exposure Medical Procedures

August 19, 2026—Radiation Detection Company (RDC), a provider of occupational dosimetry services with a comprehensive portfolio of radiation monitoring solutions, announced the launch of Radiant real-time dosimetry.

CIRSE Access to Care Initiative Seeks to Strengthen IR Training and Treatment in Africa and Eastern Europe

August 18, 2026—The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) has launched the Access to Care initiative, a comprehensive capacity-building program to support access to interventional radiology (IR) treatment and IR training through targeted, regional activities.

Galvanize’s Aliya EX System Used in First Commercial Procedures for Ablation of Soft Tissue

August 17, 2026—Galvanize Therapeutics, Inc., a developer of pulsed electric field (PEF) therapies for oncology and chronic lung disease, announced the completion of the first commercial procedures using its Aliya EX system.

WallabyPhenox PROMISE Registry of MeVO Stroke Treatment Begins Enrollment

August 14, 2026—WallabyPhenox announced that the first patient has been enrolled in the PROMISE registry, an investigator-initiated, prospective study on the management of ischemic stroke secondary to medium vessel occlusion (MeVO) acute ischemic stroke.

Jupiter Endovascular Appoints Dr. Catalin Toma as Chief Medical Officer

August 13, 2026—Jupiter Endovascular Inc., announced the appointment of interventional cardiologist Catalin Toma, MD, as Chief Medical Officer.

Vesalio’s pVasc Net Mechanical Thrombectomy Device Receives FDA 510(k) Clearance

August 13, 2026—Vesalio announced that the FDA has granted 510(k) clearance for pVasc Net, the company’s next-generation peripheral mechanical thrombectomy device with an integrated distal filter.

ARPA-H Funding Will Support Teams to Advance Robotics Stroke Interventions

August 12, 2026—The Advanced Research Projects Agency for Health (ARPA-H), an agency within the United States Department of Health and Human Services, announced contract awards to seven teams through its Autonomous Interventions and Robotics (AIR) program to develop autonomous robotic systems and microbots for the treatment of stroke.

FastWave’s SPARC Pivotal Trial of Artero Peripheral IVL System Receives IDE Approval

August 11, 2026—FastWave Medical announced that it has received FDA approval of an investigational device exemption for the United States pivotal trial of the company’s Artero electric intravascular lithotripsy system for the treatment of peripheral artery disease.

Penumbra Appoints Dr. Donald Frei as Associate Chief Medical Officer of Neuro

August 11, 2026—Penumbra announced today that Donald Frei, MD, will serve as Associate Chief Medical Officer of Neuro.